Skip to content

Evaluation of the 755nm Alexandrite for Unwanted Tattoos

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01842815
Enrollment
20
Registered
2013-04-30
Start date
2013-03-31
Completion date
2015-12-31
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unwanted, Non Cosmetic, Tattoos

Brief summary

The purpose of this study is to collect further data on the safety and efficacy of removing unwanted non cosmetic tattoos (including recalcitrant) using a 755nm Alexandrite laser.

Interventions

DEVICE755 nm alexandrite laser

755 nm alexandrite laser for the treatment of unwanted, non cosmetic, tattoos.

Sponsors

Cynosure, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Is a healthy male or female between 18 and 85 years old. 2. Has unwanted non-cosmetic tattoo(s) and wishes to undergo laser treatments to remove them. 3. Is willing to consent to participate in the study. 4. Is willing to comply with all requirements of the study including being photographed, following post treatment care and attending all treatment and follow up visits.

Exclusion criteria

1. Is hypersensitive to light exposure. 2. Has active localized or systemic infection. 3. Is taking medication(s) for which sunlight is a contraindication. 4. Has a history of squamous cell carcinoma or melanoma. 5. Has a history of keloid scarring. 6. Has used oral isotretinoin (Accutane®) within 12 months of initial treatment or plans on using during the course of the study. Note: Skin must regain its normal degree of moisture prior to treatment. 7. Has a history of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or use of immunosuppressive medications. 8. Is female and pregnant, has been pregnant within the last 3 months, is currently breast feeding or planning a pregnancy during the study period. 9. Is allergic to lidocaine, tetracaine or Xylocaine with epinephrine. 10. Has any other reason determined by the physician to be ineligible to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Tattoo ClearancePost Treatment 1 (6 Weeks Post Baseline)Clearance will be measured using a clearance aesthetic improvement scale. This scale ranges from 0 to 10, where 0 is 0% tattoo cleared compared to the baseline tattoo, and 10 is 100% of tattoo cleared compared to the baseline tattoo.

Countries

United States

Participant flow

Pre-assignment details

All subjects are enrolled in both study arms because all subjects will be receiving treatment on the left side of the tattoo and treatment on the right side of the tattoo in each visit.

Participants by arm

ArmCount
755nm Alexandrite Laser
755nm Alexandrite Laser for Treatment of unwanted, non cosmetic tattoos 755 nm alexandrite laser: 755 nm alexandrite laser for the treatment of unwanted, non cosmetic, tattoos.
19
Total19

Baseline characteristics

Characteristic755nm Alexandrite Laser
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
19 Participants
Fitzpatrick Skin Type
Fitzpatrick Skin Type I
1 Participants
Fitzpatrick Skin Type
Fitzpatrick Skin Type II
6 Participants
Fitzpatrick Skin Type
Fitzpatrick Skin Type III
7 Participants
Fitzpatrick Skin Type
Fitzpatrick Skin Type IV
4 Participants
Fitzpatrick Skin Type
Fitzpatrick Skin Type V
1 Participants
Fitzpatrick Skin Type
Fitzpatrick Skin Type VI
0 Participants
Race/Ethnicity, Customized
Race/Ethnicity
African American
1 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Asian
0 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Caucasian
12 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Hispanic
4 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Native American
1 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Other
1 Participants
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
14 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 20
other
Total, other adverse events
4 / 20
serious
Total, serious adverse events
0 / 20

Outcome results

Primary

Tattoo Clearance

Clearance will be measured using a clearance aesthetic improvement scale. This scale ranges from 0 to 10, where 0 is 0% tattoo cleared compared to the baseline tattoo, and 10 is 100% of tattoo cleared compared to the baseline tattoo.

Time frame: Post Treatment 1 (6 Weeks Post Baseline)

ArmMeasureValue (MEAN)Dispersion
755nm Alexandrite Laser Single Pass (Right Side).Tattoo Clearance2.875 score on a scaleStandard Deviation 2.112
755nm Alexandrite Laser Double Pass (Left Side)Tattoo Clearance4.25 score on a scaleStandard Deviation 2.513
Comparison: This t-test is to test the statistical significance of the right side of the tattoo clearance vs. the left side of the tattoo clearance. It tests if there is a difference between the tattoo being treated twice per visit (right side) vs. being treated once per visit (left side).p-value: 0.0077t-test, 2 sided
Primary

Tattoo Clearance

Clearance will be measured using a clearance aesthetic improvement scale. This scale ranges from 0 to 10, where 0 is 0% tattoo cleared compared to the baseline tattoo, and 10 is 100% of tattoo cleared compared to the baseline tattoo.

Time frame: Post Treatment 2 (12 Weeks Post Baseline)

ArmMeasureValue (MEAN)Dispersion
755nm Alexandrite Laser Single Pass (Right Side).Tattoo Clearance3.75 score on a scaleStandard Deviation 2.21
755nm Alexandrite Laser Double Pass (Left Side)Tattoo Clearance4.88 score on a scaleStandard Deviation 2.58
Comparison: This t-test is to test the statistical significance of the right side of the tattoo clearance vs. the left side of the tattoo clearance. It tests if there is a difference between the tattoo being treated twice per visit (right side) vs. being treated once per visit (left side).p-value: 0.00012t-test, 2 sided
Primary

Tattoo Clearance

Clearance will be measured using a clearance aesthetic improvement scale. This scale ranges from 0 to 10, where 0 is 0% tattoo cleared compared to the baseline tattoo, and 10 is 100% of tattoo cleared compared to the baseline tattoo.

Time frame: Post Treatment 3 (18 Weeks Post Baseline)

ArmMeasureValue (MEAN)Dispersion
755nm Alexandrite Laser Single Pass (Right Side).Tattoo Clearance4.5 score on a scaleStandard Deviation 2.48
755nm Alexandrite Laser Double Pass (Left Side)Tattoo Clearance5.77 score on a scaleStandard Deviation 2.83
Comparison: This t-test is to test the statistical significance of the right side of the tattoo clearance vs. the left side of the tattoo clearance. It tests if there is a difference between the tattoo being treated twice per visit (right side) vs. being treated once per visit (left side).p-value: 0.0034t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026